Based on the above evidence, we hypothesized that the KDM4A/HIF1α/DDIT4/mTOR axis might be involved in the development of NPC and therefore investigated its underlying regulatory mechanism, with the aim of identifying new therapeutic targets for the treatment of NPC. This evidence concerns the gene MTOR and nasopharyngeal carcinoma.